Kokkinis E, Bastas N, Mega I, Tsironis C, Lianou A
Maedica (Bucur). 2025; 19(4):801-806.
PMID: 39974435
PMC: 11834829.
DOI: 10.26574/maedica.2024.19.4.8012024;.
Jortso E, Marklund L, Harper Hysek M, Nasman A, Hammarstedt-Nordenvall L, Von Beckerath M
Acta Oncol. 2025; 64:276-283.
PMID: 39962709
PMC: 11848946.
DOI: 10.2340/1651-226X.2025.42078.
Karlsson C, Bohm N, Andersson J, Finizia C, Almstahl A
BMC Oral Health. 2024; 24(1):697.
PMID: 38879501
PMC: 11180409.
DOI: 10.1186/s12903-024-04466-5.
Sethi S, Shahin A, Rahim I
Indian J Otolaryngol Head Neck Surg. 2024; 76(1):268-276.
PMID: 38440648
PMC: 10908725.
DOI: 10.1007/s12070-023-04140-2.
Saiya P, Jantharapattana K, Dechaphunkul A, Jirapongsak J, Thongsuksai P
Asian Pac J Cancer Prev. 2024; 25(1):57-64.
PMID: 38285767
PMC: 10911748.
DOI: 10.31557/APJCP.2024.25.1.57.
HPV-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions.
Lim Y, DSilva N
Oncogene. 2024; 43(8):543-554.
PMID: 38191674
PMC: 10873204.
DOI: 10.1038/s41388-023-02927-9.
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century.
Zitricky F, Koskinen A, Hemminki O, Forsti A, Hemminki A, Hemminki K
Cancer Med. 2024; 13(1):e6867.
PMID: 38164108
PMC: 10807619.
DOI: 10.1002/cam4.6867.
Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis.
Fonseca T, Jural L, Maranon-Vasquez G, Magno M, Roza A, Ferreira D
Clin Oral Investig. 2023; 28(1):62.
PMID: 38158517
DOI: 10.1007/s00784-023-05425-0.
Transoral Ultrasound in the Outpatient Clinic for the Diagnostic Work-Up of Oropharyngeal Cancer: A Feasibility Study.
Garset-Zamani M, Norling R, Hahn C, Agander T, von Buchwald C, Todsen T
Cancers (Basel). 2023; 15(21).
PMID: 37958465
PMC: 10649062.
DOI: 10.3390/cancers15215292.
Rising Trend in the Prevalence of HPV-Driven Oropharyngeal Squamous Cell Carcinoma during 2000-2022 in Northeastern Italy: Implication for Using p16 as a Surrogate Marker for HPV-Driven Carcinogenesis.
Boscolo-Rizzo P, Polesel J, Del Mistro A, Fratta E, Lazzarin C, Menegaldo A
Cancers (Basel). 2023; 15(9).
PMID: 37174107
PMC: 10177129.
DOI: 10.3390/cancers15092643.
Conditioned Media from Head and Neck Cancer Cell Lines and Serum Samples from Head and Neck Cancer Patients Drive Catabolic Pathways in Cultured Muscle Cells.
Saroul N, Tardif N, Pereira B, Dissard A, Montrieul L, Sanchez P
Cancers (Basel). 2023; 15(6).
PMID: 36980729
PMC: 10047086.
DOI: 10.3390/cancers15061843.
Accuracy of p16 IHC in Classifying HPV-Driven OPSCC in Different Populations.
Gallus R, Nauta I, Marklund L, Rizzo D, Crescio C, Mureddu L
Cancers (Basel). 2023; 15(3).
PMID: 36765613
PMC: 9913822.
DOI: 10.3390/cancers15030656.
Single-cell analysis of myeloid cells in HPV tonsillar cancer.
Jimenez D, Altunbulakli C, Swoboda S, Sobti A, Askmyr D, Ali A
Front Immunol. 2023; 13:1087843.
PMID: 36741389
PMC: 9893928.
DOI: 10.3389/fimmu.2022.1087843.
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited.
Byskata K, Lukoseviciute M, Tuti F, Zupancic M, Kostopoulou O, Holzhauser S
Cancers (Basel). 2023; 15(1).
PMID: 36612094
PMC: 9818008.
DOI: 10.3390/cancers15010093.
Analysis of the Prevalence and Quantification of viral load of different human papillomavirus types in Turkish women population.
Tekkesin N, Goktas S, Alkis V, Koc S, Gurbuz T, Goktas P
Asian Pac J Cancer Prev. 2022; 23(12):4347-4355.
PMID: 36580019
PMC: 9971451.
DOI: 10.31557/APJCP.2022.23.12.4347.
Human Papillomavirus-Related Non-Metastatic Oropharyngeal Carcinoma: Current Local Treatment Options and Future Perspectives.
Svajdova M, Dubinsky P, Kazda T, Jeremic B
Cancers (Basel). 2022; 14(21).
PMID: 36358801
PMC: 9658535.
DOI: 10.3390/cancers14215385.
Post-Treatment Neck Dissection of Tonsillar and Base of Tongue Squamous Cell Carcinoma in the Era of PET-CT, HPV, and p16.
Landin D, Nasman A, Jara S, Hammarstedt-Nordenvall L, Munck-Wikland E, Dalianis T
Viruses. 2022; 14(8).
PMID: 36016315
PMC: 9413897.
DOI: 10.3390/v14081693.
The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
Zhou P, Chen D, Lian C, Wu S, Zhang S
Front Public Health. 2022; 10:900294.
PMID: 35958856
PMC: 9358251.
DOI: 10.3389/fpubh.2022.900294.
Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors.
Kostopoulou O, Zupancic M, Pont M, Papin E, Lukoseviciute M, Mikelarena B
Viruses. 2022; 14(7).
PMID: 35891353
PMC: 9320646.
DOI: 10.3390/v14071372.
Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe.
Rubio-Casadevall J, Ciurana E, Puigdemont M, Sanvisens A, Marruecos J, Miro J
Int J Environ Res Public Health. 2022; 19(8).
PMID: 35457669
PMC: 9027195.
DOI: 10.3390/ijerph19084802.
